Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
about
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsImpact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria.Anaemia in a phase 2 study of a blood stage falciparum malaria vaccineCombining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.New insights for native production of MSP1(19), the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1.Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunizationThe biology of Plasmodium vivax explored through genomicsPhase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.Allelic Diversity and Geographical Distribution of the Gene Encoding Plasmodium falciparum Merozoite Surface Protein-3 in Thailand.Approaching the target: the path towards an effective malaria vaccine.Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates.Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?Particle-based platforms for malaria vaccines.Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodiesChallenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccinesDiversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1Overview of plant-made vaccine antigens against malaria.Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum.Production, characterization, and immunogenicity of a secreted form of Plasmodium falciparum merozoite surface protein 4 produced in Bacillus subtilis.Malaria Vaccine Development: The Need for Novel Approaches: A Review Article.
P2860
Q28731894-A3FDC22D-41A7-4865-9A65-DA4E4653AA04Q33974904-E00EB6F1-6494-4A30-9592-90748C194A48Q34441098-9104DF16-AB46-489D-B5B3-24C5C99C9504Q34564544-BEFBE05D-0B62-4DBE-ACF4-AB374C5547F2Q34600955-C63D621A-BC63-4C54-8AB9-E972D5953E4DQ34602992-976B93CF-68E6-4311-9020-347C34048136Q34613585-6C18E826-E191-41A6-97D2-20EDB2E4BD11Q35194707-5A986702-59DC-464C-B68A-B84ED59F1AE4Q35211003-3E5DDB92-EC6B-4E48-A2C3-C3C367680CC7Q35513867-6C751310-1F49-44AE-826B-DFA862FF85C5Q35557657-31CA5C72-793C-4DAD-B5B5-0558E6237814Q35559584-C44C61A9-7A43-4F64-BF03-73EECDDBDE7BQ35924716-3D86A526-9175-48DB-8391-F0D44B5D9FDBQ36053587-E5400AE8-4FC3-43CA-BF42-D7B8C0180FE7Q36368017-BE7B5833-E738-4653-9242-C2C1CD40A234Q36391845-AE7AF313-C0DA-441A-BDBE-73F979A85544Q36396040-EFAB2917-0AAE-4B2D-8061-8415D8D60184Q36686924-73FB15BF-1D7A-42FB-A0BE-ED54430B8523Q37264673-1E8BA0D2-CAE4-43A0-9B38-FE309B45B19DQ37530299-221BAAAB-2A3E-46E4-BF39-95289CC19DEDQ37597218-AAB5C625-DFAD-48CB-848D-B1630E91220FQ38036581-9A479E0E-22D8-44B0-84E5-3D320D1966BBQ42127731-0C91AEC8-B91A-4CAD-B6FB-D77C8170E6BEQ47841730-5D83437A-7D76-4B8D-BA16-F92ED97C394AQ55379631-67AD8FDE-234E-4219-9515-562E003BAEFD
P2860
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@ast
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@en
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@nl
type
label
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@ast
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@en
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@nl
prefLabel
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@ast
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@en
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@nl
P2860
P50
P356
P1433
P1476
Blood stage vaccines for Plasmodium falciparum: current status and the way forward.
@en
P2093
P2860
P304
P356
10.4161/HV.6.8.11446
P577
2010-08-01T00:00:00Z